Add-on plasma exchange for new septic shock
Part of Infections clinical trials.
This study tests whether adding plasma exchange (a blood-cleaning treatment) to usual care can improve outcomes for people with new septic shock. If you qualify, you may receive this treatment soon after septic shock is diagnosed to help your body recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have new septic shock diagnosed within the last 24 hours
- You need strong blood-pressure support with medications (like norepinephrine, with or without vasopressin) at certain levels
- You already have a suitable access line/IV setup for plasma exchange, or your team expects you may need a similar kidney-support treatment soon
- You are between 18 and 80 years old
- Your infection is not mainly in the urinary or genital tract
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether therapeutic plasma exchange (a procedure that removes and replaces blood plasma) can improve outcomes in ICU patients with septic shock that is not responding to standard medicines. It may help some people whose infection-related illness is causing failing organs.
This trial tests a new way to treat sepsis in children by using plasma (a part of blood) to help restore blood flow. It compares plasma to standard IV fluids for children who are very sick from infection.
This trial tests a special blood filter (hemoadsorption) for people in septic shock (a severe infection causing very low blood pressure). It aims to see if the filter helps remove harmful substances from the blood and improve recovery.
This trial tests a special blood-filtering method (adaptive blood purification) for people with septic shock caused by a severe infection. It aims to see if this treatment can help control inflammation and improve recovery in the ICU.
This trial tests a new way to manage fluids and blood pressure medicines in patients with septic shock. It aims to find if using a specific blood flow measurement (capillary refill time) can improve outcomes compared to standard care.
This trial tests whether a blood filtering treatment called hemoadsorption can help protect blood vessels in people with septic shock. It may be an option for patients who are already on strong blood pressure medications and steroids.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.